Hydromorphone Hydrochloride 00574-0295
Product NDC
00574-0295- Manufacturer
- Padagis Us Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 22, 2015
- Listing Expires
- December 31, 2027
- Application
- ANDA204278
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 16 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01)